Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Dominic Rowe

Macquarie University

Australia

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Neurology

100%

Biostatistics

50%

Amyotrophic Lateral Sclerosis

90%

Neurodegenerative Disease

90%

Medical Science

50%

Genomic

40%

Neuroprotection

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Motor Neurone Disease: Patient centred care for a progressive neurological disease - evidence driving policy.

Open Date: 2018-01-01

Close Date:

Grant: Close

Non-Alzheimerâ s disease degenerative dementias: Identifying prodromal genetic/familial phenotypes, modifying factors, and protein variations involved in progression

Open Date: 2015-01-01

Close Date: 2020-12-31

Grant: Close

The Australian Parkinson's Project - Uncovering genetic risk factors for sporadic PD

Open Date: 2006-01-01

Close Date: 2008-12-31

Grant: Close

Development of a novel diagnostic test for the death of neuromelanin-containing dopamine neurons in the human brain

Open Date: 2003-01-01

Close Date: 2005-12-31

Grant: Close

Glia and Parkinson's disease

Open Date: 2003-01-01

Close Date: 2005-12-31

Articles16

C9orf72-associated dipeptide repeat expansions perturb ER-golgi vesicular trafficking, inducing golgi fragmentation and ER stress, in ALS/FTD

Article Link

Year:

2024

Short tandem repeat expansions in LRP12 are absent in cohorts of familial and sporadic amyotrophic lateral sclerosis patients of European ancestry

Article Link

Year:

2024

Letter to the editor on

Article Link

Year:

2024

Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia

Article Link

Year:

2023

Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS

Article Link

Year:

2023

Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis

Article Link

Year:

2023

The importance of patient‐centred drug development for amyotrophic lateral sclerosis

Article Link

Year:

2023

Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis

Article Link

Year:

2023

RNA sequencing of peripheral blood in amyotrophic lateral sclerosis reveals distinct molecular subtypes: Considerations for biomarker discovery

Article Link

Year:

2023

NEK1 and STMN2 short tandem repeat lengths are not associated with Australian amyotrophic lateral sclerosis risk

Article Link

Year:

2022

Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS

Article Link

Year:

2022

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

Article Link

Year:

2022

Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia

Article Link

Year:

2021

Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

Article Link

Year:

2021

Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophrenia

Article Link

Year:

2021

Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis

Article Link

Year:

2021

Collaborators40

Marta Vidal

Macquarie University

AUSTRALIA

Julia Stevens

University of Sydney

AUSTRALIA

Sina Shadfar

Macquarie University

AUSTRALIA

Jillian Kril

faculty of medicine and health sciences macquarie university sydney nsw australia

AUSTRALIA

Ian Blair

Macquarie University

AUSTRALIA

Yazi Ke

Macquarie University

AUSTRALIA

Andrew Smith

Macquarie University

AUSTRALIA

Sidong Liu

Macquarie University

AUSTRALIA

Cyril Jones Jagaraj

Macquarie University

AUSTRALIA

Eilis Hannon

University of Exeter Medical School

UNITED KINGDOM

Julie Atkin

Macquarie University

AUSTRALIA

Charles Curtis

King’s College London

UNITED KINGDOM

Bradley Smith

King’s College London

UNITED KINGDOM

Stéphanie Millecamps

Sorbonne Université

FRANCE

Sandrine Chan Moi Fat

Macquarie University

AUSTRALIA

Natalie Grima

Macquarie University

AUSTRALIA

Sandra D'Alfonso

Università degli Studi del Piemonte Orientale Amedeo Avogadro

ITALY

Sonam Parakh

Macquarie University

AUSTRALIA

Michael Sendtner

Professor for Clinical Neurobiology

University of Würzburg

GERMANY

Viviana Pensato

Fondazione IRCCS Istituto Neurologico Carlo Besta

ITALY

simon topp

King’s College London

UNITED KINGDOM

Rachel H Tan

University of Sydney

AUSTRALIA

Saravanabavan Sayanthooran

Macquarie University

AUSTRALIA

Anand Deva

Macquarie University

AUSTRALIA

Ewout J. N. Groen

NETHERLANDS

Frederik Steyn

Senior Lecturer/Group Leader

University of Queensland

AUSTRALIA

Kelly Williams

Macquarie University

AUSTRALIA

Mark K Bakker

NETHERLANDS

Emily Don

Macquarie University

AUSTRALIA

Emily McCann

Macquarie University

AUSTRALIA

Lyndal Henden

Macquarie University

AUSTRALIA

Shu Yang

Macquarie University

AUSTRALIA

Sharlynn Wu

Macquarie University

AUSTRALIA

Julia Kraft

Charité - Universitätsmedizin Berlin

GERMANY

Yue Yang

University of Sydney

AUSTRALIA

Sarah Furlong

Macquarie University

AUSTRALIA

Alfredo Iacoangeli

King’s College London

UNITED KINGDOM

Beben Benyamin

University of South Australia

AUSTRALIA

John Landers

University of Massachusetts Chan Medical School

UNITED STATES

Angelica Nordin

University Hospital of Umeå

SWEDEN

How do I reach out?

Meet Kite AI